Chengda Pharmaceuticals Co (SZSE:301201) Institutional Ownership: 2.06% (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:301201 Chengda Pharmaceuticals Co Ltd SZSE:301201
78 GF Score
Price ¥29.75
GF Value ¥30.45
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Chengda Pharmaceuticals Co Institutional Ownership?

Chengda Pharmaceuticals Co SZSE:301201 +5.46% 78 Institutional Ownership is 2.06% as of Aug. 04, 2026. GuruFocus rates SZSE:301201 with a GF Score™ of 78/100 and a GF Value™ of ¥30.45 (Fairly Valued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Chengda Pharmaceuticals Co's institutional ownership is 2.06%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Chengda Pharmaceuticals Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Chengda Pharmaceuticals Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Chengda Pharmaceuticals Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Chengda Pharmaceuticals Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chengda Pharmaceuticals Co Institutional Ownership Chart

Chengda Pharmaceuticals Co Historical Data

The historical data trend for Chengda Pharmaceuticals Co can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.05 0.05 0.05 2.06 2.06 2.06 2.06 2.06 2.06 2.06
SZSE:301201
78GF Score
Chengda Pharmaceuticals Co Ltd SZSE:301201
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chengda Pharmaceuticals Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.06% mean?
Chengda Pharmaceuticals Co (SZSE:301201) has a Institutional Ownership of 2.06% as of Aug. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chengda Pharmaceuticals Co and its competitors.
Is Chengda Pharmaceuticals Co's Institutional Ownership too high?
Chengda Pharmaceuticals Co's current Institutional Ownership is 2.06%. Overall, Chengda Pharmaceuticals Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chengda Pharmaceuticals Co's Institutional Ownership compare to ZTS?
Chengda Pharmaceuticals Co's Institutional Ownership of 2.06% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chengda Pharmaceuticals Co and its competitors. Chengda Pharmaceuticals Co's current Institutional Ownership is 2.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chengda Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Chengda Pharmaceuticals Co (SZSE:301201) is currently considered Fairly Valued. The stock's GF Value™ is ¥30.45, compared to a current price of ¥29.75 — trading 2.3% below its estimated fair value. The current Institutional Ownership is 2.06%. Chengda Pharmaceuticals Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Chengda Pharmaceuticals Co (SZSE:301201), the current Institutional Ownership is 2.06% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chengda Pharmaceuticals Co (SZSE:301201) Overvalued in 2026?

Based on GuruFocus' analysis, Chengda Pharmaceuticals Co stock appears to be undervalued. The current stock price of ¥29.75 is trading 2.3% below its estimated GF Value™ of ¥30.45. GuruFocus considers Chengda Pharmaceuticals Co to be Fairly Valued.

Key valuation signals for SZSE:301201:

  • Institutional Ownership: 2.06%
  • GF Value™: ¥30.45 vs. price of ¥29.75 (2.3% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the SZSE:301201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chengda Pharmaceuticals Co Business Description

Address 36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100
Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.
78GF Score

Get the complete analysis for SZSE:301201

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.75
Price
¥30.45
GF Value